In the published article, there were multiple errors in Table 2 as published. The values in Table 2 as seen below have been corrected.
Table 2
| Healthy volunteers | Males | Females | P value | |
|---|---|---|---|---|
| N = 34 | N = 13 | N = 21 | ||
| Age (years) | 31 ± 7.1 | 30.8 ± 7.1 | 29.9 ± 6.9 | 0.596 |
| Secretoneurin | 50.7 ± 16.3 | 50.7 ± 15.3 | 50.7 ± 16.3 | 0.64 |
| Body weight (kg) | 69 ± 14 | 69 ± 14 | 67 ± 14 | 0.001 |
| Body height (cm) | 171.8 ± 8.9 | 171.8 ± 8.9 | 170.8 ± 8.9 | <0.001 |
| Body mass index (kg/m2) | 23.2 ± 3.6 | 23.1 ± 3.6 | 23 ± 3.6 | 0.477 |
| NT-pro-BNP | 55.5 ± 29.2 | 55.5 ± 29.2 | 57.5 ± 30 | 0.066 |
| Creatinine | 74.1 ± 12.45 | 74.1.1 ± 12.45 | 71.9 ± 10.6 | <0.001 |
| Natrium | 138.2 ± 1.75 | 138.2 ± 1.75 | 138.2 ± 1.76 | 0.208 |
| Potassium | 4.1 ± 0.29 | 4.1 ± 0.29 | 4.1 ± 0.3 | 0.03 |
| Ca2+ (ionized) | 1.17 ± 0.1 | 1.2 ± 0.1 | 1.17 ± 0.1 | 0.519 |
| Total calcium | 2.48 ± 0.13 | 2.48 ± 0.11 | 2.48 ± 0.13 | 0.079 |
| Mg2+ | 0.79 ± 0.1 | 0.79 ± 0.1 | 0.79 ± 0.05 | 0.341 |
| hs-TnI | 8.1 ± 29.4 | 8.1 ± 29.42 | 8.6 ± 31 | 0.195 |
| Hs-CRP | 1.8 ± 2.36 | 1.8 ± 2.4 | 2 ± 2.4 | 0.026 |
| IL-6 | 3.1 ± 2.6 | 3.1 ± 2.6 | 3.2 ± 2.8 | 0.440 |
| Leukocytes | 7.52 ± 1.7 | 7.5 ± 1.7 | 7.5 ± 1.6 | 0.201 |
| Thrombocytes | 280 ± 59.1 | 280 ± 59.1 | 281.8 ± 59 | 0.013 |
Baseline characteristics of the healthy volunteers.
Indices are shown as mean ± standard deviation and compared for males and females. Ca2+, ionized calcium; Hs-TnI, high-sensitivity Troponine I; IL-6, interleukin 6; Mg2+, ionized magnesium; NT-pro-BNP, N-terminal-pro-brain natriuretic peptide.
The corrected Table 2 and its caption appear below.
Table 2
| Healthy volunteers | Males | Females | P value | |
|---|---|---|---|---|
| N = 34 | N = 13 | N = 21 | ||
| Age (years) | 31 ± 7.1 | 30.8 ± 7.1 | 29.9 ± 6.9 | 0.596 |
| Secretoneurin | 50.3 ± 15 | 50.2 ± 15.1 | 50.7 ± 15.5 | 0.64 |
| Body weight (kg) | 69.1 ± 13.5 | 70 ± 14 | 66.6 ± 13 | 0.47 |
| Body height (cm) | 171.1 ± 8.9 | 172 ± 8.7 | 170.6 ± 8.8 | 0.52 |
| Body mass index (kg/m2) | 23.2 ± 3.6 | 23.1 ± 3.6 | 23 ± 3.6 | 0.477 |
| NT-pro-BNP | 55.4 ± 28.7 | 58.1 ± 31.4 | 53.6 ± 28.9 | 0.066 |
| Creatinine | 73 ± 10.9 | 75.6 ± 10.1 | 72.3 ± 10.3 | 0.36 |
| Natrium | 138.2 ± 1.73 | 138 ± 1.8 | 138.1 ± 1.7 | 0.208 |
| Potassium | 4.1 ± 0.3 | 4.1 ± 0.29 | 4.1 ± 0.3 | 0.03 |
| Ca2+ (ionized) | 1.17 ± 0.1 | 1.2 ± 0.1 | 1.17 ± 0.1 | 0.519 |
| Total calcium | 2.48 ± 0.13 | 2.48 ± 0.11 | 2.48 ± 0.13 | 0.079 |
| Mg2+ | 0.79 ± 0.1 | 0.79 ± 0.1 | 0.79 ± 0.05 | 0.341 |
| hs-TnI | 8.6 ± 30 | 10.2 ± 34.2 | 8.8 ± 30.1 | 0.9 |
| Hs-CRP | 1.9 ± 2.4 | 1.5 ± 1.7 | 2 ± 2.4 | 0.45 |
| IL-6 | 3.1 ± 2.6 | 3.1 ± 2.6 | 3.2 ± 2.8 | 0.440 |
| Leukocytes | 7.52 ± 1.7 | 7.5 ± 1.7 | 7.5 ± 1.6 | 0.201 |
| Thrombocytes | 277.5 ± 59.8 | 271.3 ± 64 | 280.4 ± 59.8 | 0.69 |
Baseline characteristics of the healthy volunteers.
Indices are shown as mean ± standard deviation and compared for males and females. Ca2+, ionized calcium; Hs-TnI, high-sensitivity Troponine I; IL-6, interleukin 6; Mg2+, ionized magnesium; NT-pro-BNP, N-terminal-pro-brain natriuretic peptide.
The authors apologize for this errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
In the published article, there was an error in assumptions about differences in males and females in the healthy volunteers group.
A correction has been made to Results. This sentence previously stated:
“Males and females in the healthy individuals group differed in anthropometric parameters, plasma creatinine level, hs-CRP, and thrombocyte count (Table 2)”.
The corrected sentence appears below:
“Males and females in the healthy individuals’ group did not differ in any parameters (Table 2)”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
secretoneurin, heart failure, CaMKII, dilated cardiomyopathy, ischaemic cardiomyopathy
Citation
Plášek J, Dodulík J, Lazárová M, Stejskal D, Švagera Z, Chobolová N, Šulc P, Evin L, Purová D and Václavík J (2024) Corrigendum: Secretoneurin levels are higher in dilated cardiomyopathy than in ischaemic cardiomyopathy: preliminary results. Front. Cardiovasc. Med. 11:1392484. doi: 10.3389/fcvm.2024.1392484
Received
27 February 2024
Accepted
19 March 2024
Published
03 April 2024
Volume
11 - 2024
Edited and reviewed by
Matteo Cameli, University of Siena, Italy
Updates
Copyright
© 2024 Plášek, Dodulík, Lazárová, Stejskal, Švagera, Chobolová, Šulc, Evin, Purová and Václavík.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jiří Plášek jiri.plasek@fno.cz
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.